全文获取类型
收费全文 | 2001篇 |
免费 | 113篇 |
国内免费 | 24篇 |
专业分类
耳鼻咽喉 | 16篇 |
儿科学 | 84篇 |
妇产科学 | 33篇 |
基础医学 | 226篇 |
口腔科学 | 20篇 |
临床医学 | 183篇 |
内科学 | 388篇 |
皮肤病学 | 75篇 |
神经病学 | 185篇 |
特种医学 | 133篇 |
外科学 | 350篇 |
综合类 | 11篇 |
预防医学 | 129篇 |
眼科学 | 98篇 |
药学 | 116篇 |
中国医学 | 2篇 |
肿瘤学 | 89篇 |
出版年
2023年 | 5篇 |
2022年 | 12篇 |
2021年 | 33篇 |
2020年 | 14篇 |
2019年 | 42篇 |
2018年 | 49篇 |
2017年 | 34篇 |
2016年 | 37篇 |
2015年 | 52篇 |
2014年 | 34篇 |
2013年 | 82篇 |
2012年 | 86篇 |
2011年 | 109篇 |
2010年 | 85篇 |
2009年 | 70篇 |
2008年 | 102篇 |
2007年 | 99篇 |
2006年 | 84篇 |
2005年 | 113篇 |
2004年 | 78篇 |
2003年 | 96篇 |
2002年 | 85篇 |
2001年 | 64篇 |
2000年 | 102篇 |
1999年 | 68篇 |
1998年 | 41篇 |
1997年 | 52篇 |
1996年 | 50篇 |
1995年 | 34篇 |
1994年 | 21篇 |
1993年 | 10篇 |
1992年 | 34篇 |
1991年 | 21篇 |
1990年 | 33篇 |
1989年 | 30篇 |
1988年 | 30篇 |
1987年 | 13篇 |
1986年 | 23篇 |
1985年 | 19篇 |
1984年 | 6篇 |
1983年 | 20篇 |
1982年 | 7篇 |
1981年 | 5篇 |
1980年 | 6篇 |
1978年 | 5篇 |
1977年 | 9篇 |
1976年 | 8篇 |
1975年 | 5篇 |
1966年 | 4篇 |
1965年 | 4篇 |
排序方式: 共有2138条查询结果,搜索用时 203 毫秒
61.
Marie-Laure Thibult Jean-Paul Rivals Emilie Mamessier Julie Gertner-Dardenne Sonia Pastor Daniel E. Speiser Laurent Derré Daniel Olive 《Journal of molecular medicine (Berlin, Germany)》2013,91(2):195-205
BTLA (B- and T-lymphocyte attenuator) is a prominent co-receptor that is structurally and functionally related to CTLA-4 and PD-1. In T cells, BTLA inhibits TCR-mediated activation. In B cells, roles and functions of BTLA are still poorly understood and have never been studied in the context of B cells activated by CpG via TLR9. In this study, we evaluated the expression of BTLA depending on activation and differentiation of human B cell subsets in peripheral blood and lymph nodes. Stimulation with CpG upregulated BTLA, but not its ligand: herpes virus entry mediator (HVEM), on B cells in vitro and sustained its expression in vivo in melanoma patients after vaccination. Upon ligation with HVEM, BTLA inhibited CpG-mediated B cell functions (proliferation, cytokine production, and upregulation of co-stimulatory molecules), which was reversed by blocking BTLA/HVEM interactions. Interestingly, chemokine secretion (IL-8 and MIP1β) was not affected by BTLA/HVEM ligation, suggesting that BTLA-mediated inhibition is selective for some but not all B cell functions. We conclude that BTLA is an important immune checkpoint for B cells, as similarly known for T cells. 相似文献
62.
AMJ van Wegberg RAF Evers JGM Burgerhof E van Dam M.R. Heiner-Fokkema MCH Janssen MC de Vries FJ van Spronsen 《Molecular genetics and metabolism》2021,132(1):49-55
BackgroundIn patients with phenylketonuria, stability of blood phenylalanine and tyrosine concentrations might influence brain chemistry and therefore patient outcome. This study prospectively investigated the effects of tetrahydrobiopterin (BH4), as a chaperone of phenylalanine hydroxylase on diurnal and day-to-day variations of blood phenylalanine and tyrosine concentrations.MethodsBlood phenylalanine and tyrosine were measured in dried blood spots (DBS) four times daily for 2 days (fasting, before lunch, before dinner, evening) and once daily (fasting) for 6 days in a randomized cross-over design with a period with BH4 and a period without BH4. The sequence was randomized. Eleven proven BH4 responsive PKU patients participated, 5 of them used protein substitutes during BH4 treatment. Natural protein intake and protein substitute dosing was adjusted during the period without BH4 in order to keep DBS phenylalanine levels within target range. Patients filled out a 3-day food diary during both study periods. Variations of DBS phenylalanine and Tyr were expressed in standard deviations (SD) and coefficient of variation (CV).ResultsBH4 treatment did not significantly influence day-to-day phenylalanine and tyrosine variations nor diurnal phenylalanine variations, but decreased diurnal tyrosine variations (median SD 17.6 μmol/l, median CV 21.3%, p = 0.01) compared to diet only (median SD 34.2 μmol/l, median CV 43.2%). Consequently, during BH4 treatment diurnal phenylalanine/tyrosine ratio variation was smaller, while fasting tyrosine levels tended to be higher.ConclusionBH4 did not impact phenylalanine variation but decreased diurnal tyrosine and phenylalanine/tyrosine ratio variations, possibly explained by less use of protein substitute and increased tyrosine synthesis. 相似文献
63.
64.
Santiago Gonzalez-Ayora Carlos Pastor Hector Guadalajara Jose Manuel Ramirez Pablo Royo Elizabeth Redondo Antonio Arroyo Pedro Moya Damian Garcia-Olmo 《International journal of colorectal disease》2016,31(9):1625-1631
Purpose
ERAS (enhanced recovery after surgery) programs have proven to reduce morbidity and hospital stay in colorectal surgery. However, the feasibility of these programs in elderly patients has been questioned. The aim of this study is to assess the implementation and outcomes of an ERAS program for colorectal cancer in elderly patients.Methods
This is a multicenter observational study of a cohort of elderly patients undergoing colorectal surgery within an ERAS program. A total of 188 consecutive patients over 70 years who underwent elective colorectal surgery within an ERAS program at three institutions during a 2-year period were included. The compliance with the ERAS protocol interventions was measure. Complications were evaluated according to Clavien-Dindo classification. Data on length of stay and readmission rates were analyzed.Results
Early intake and early mobilization were the most successfully carried out interventions. There was a global compliance rate of 56 % of patients for whom compliance was achieved with all measured interventions. The median hospital length of stay was 6 days. Almost 60 % of patients had no complications, 24 % had minor complications while 13 % had major complications; of them, 8 % patients were reoperated. The readmission rate was 6.4 %.Conclusions
ERAS after colorectal surgery in elderly patients presents as safe and feasible based on good reported outcomes of compliance rates, complications, readmissions, and needs for reoperation.65.
Ponce de Leon D Acevedo-Vasquez E Alvizuri S Gutierrez C Cucho M Alfaro J Perich R Sanchez-Torres A Pastor C Sanchez-Schwartz C Medina M Gamboa R Ugarte M 《The Journal of rheumatology》2008,35(5):776-781
OBJECTIVE: Tuberculosis (TB) in patients with rheumatoid arthritis (RA) undergoing treatment with anti-tumor necrosis factor (TNF) agents is commonly the result of reactivation of latent TB infection (LTBI); detection and treatment of LTBI is essential before treatment with anti-TNF agents. We reported previously that the tuberculin skin test (TST) is inaccurate for diagnosis of LTBI in patients with RA. Here, we compare the prevalence of LTBI in RA patients and matched controls according to positive TST and QuantiFeron-TB Gold In-Tube version (QFT) results and determine their agreement. METHODS: A cross-sectional study of 101 RA patients and 93 controls was conducted in Lima, Perú, where the prevalence of LTBI in the general population has been estimated to be 68%. Blood was drawn for QFT assay followed by TST using 2-TU of RT 23 purified protein derivative. TST was deemed positive at >or= 5 mm for RA patients and >or= 10 mm for controls. RESULTS: There were no significant differences between RA patients and controls for age, sex, bacillus Calmette-Guérin vaccination, or history of or contact with TB. 88% of patients had active RA disease and 2 (1.9%) patients had indeterminate QFT results. The number of subjects testing positive with the QuantiFeron assay was comparable between patients and controls (44.6% vs 59.1%, respectively), whereas the TST detected significantly less LTBI among RA patients (26.7%) than controls (65.6%). Thus, the rate of LTBI in RA patients represented 75% and 41% of the rate in their controls using QFT or TST, respectively (p = 0.008). Poor agreement between TST and QFT was seen in RA patients, but in controls, good agreement was observed between these tests. CONCLUSION: In a TB-endemic population, the QuantiFeron-TB Gold In-Tube assay seemed to be a more accurate test for detection of LTBI in RA patients compared with the TST, and may potentially improve the targeting of prophylactic therapy before treatment with anti-TNF agents. 相似文献
66.
67.
68.
69.
70.
R. Laurà I. San José J.F. Pastor A. López‐Muñiz O. García‐Suárez J.A. Vega 《Anatomical record (Hoboken, N.J. : 2007)》2013,296(1):117-122
The avian Herbst corpuscles are the equivalent of the Pacinian corpuscles in mammals, and detect vibration and the movement of joints and feathers. Therefore, they can be regarded as rapidly adapting low‐threshold mechanoreceptors. In recent years, it has been establish that some ion channels are involved in mechanosensation and are present in both mechanosensory neurons and mechanoreceptors. Here we have used immunohistochemistry to localize some putative mechanoproteins in the Herbst corpuscles from the rictus of Columba livia. The proteins investigated were the subunits of the epithelial Na+ channel (ENaC), the transient‐receptor potential vanilloid 4 (TRPV4), and the acid‐sensing ion channel 2 (ASIC2). Immunoreactivity for ENaC subunits was never found in Herbst corpuscles, while the axon expressed ASIC2 and TRPV4 immunoreactivity. Moreover, TRPV4 was also detected in the cell forming the inner core. The present results demonstrate for the first time the occurrence of mechanoproteins in avian low‐threshold mechanoreceptors and provide further evidence for a possible role of the ion channels in mechanosensation. Anat Rec, 2013. © 2012 Wiley Periodicals, Inc. 相似文献